KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,064,000 | +4.9% | 58,300 | -1.2% | 5.61% | +3.5% |
Q2 2022 | $3,874,000 | -1.3% | 59,000 | 0.0% | 5.42% | +30.4% |
Q1 2022 | $3,926,000 | -4.9% | 59,000 | 0.0% | 4.15% | +39.3% |
Q4 2021 | $4,127,000 | +97.7% | 59,000 | +47.5% | 2.98% | +175.7% |
Q3 2021 | $2,088,000 | +60.9% | 40,000 | +109.7% | 1.08% | +62.2% |
Q2 2021 | $1,298,000 | – | 19,075 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |